Anticardiolipin Antibodies (aCL)
The antibody that can surface after a winter cold and be gone by spring, and why a single positive is the start of a question rather than an answer.
Part of the Autoimmune Panel — see all 16 values together, including Anti-Centromere Antibodies, Anti-Cyclic Citrullinated Peptide, Anti-Double Stranded DNA.
It can appear in the weeks after an ordinary infection and then quietly disappear, and that one fact undoes most of the worry an anticardiolipin result tends to cause. Think of it as a hand stamp from last night's show: vivid on the back of your hand in the morning, faded by lunch, gone by the time anyone asks to see it. A first positive feels permanent. Often it is not.
Anticardiolipin antibodies (aCL) are a type of autoantibody, meaning the immune system has made them against one of the body's own components rather than an outside threat. The target here is cardiolipin, a fat molecule that sits in cell membranes and is involved in the way blood clots form. When these antibodies persist, they belong to a wider family measured on the antiphospholipid antibodies workup and can tip the blood toward unwanted clotting. The test reports results in GPL units for the IgG class and MPL units for IgM, and it is one of the markers that sits across both the autoimmune panel and the coagulation panel.
The reason this page exists is the gap between what a positive looks like and what it means. Top consumer pages tend to translate "positive" straight into "increased clotting risk" and stop. The part they leave out is the part that matters most to a frightened reader: a lone positive is often a passing reaction, and it cannot, by itself, name a disease.
How a result is usually read
No meaningful antibody detected. A single in-range result is reassuring on its own.
A small rise, and the result most likely to fade on a repeat draw. Often seen after a recent infection or as an IgM-only finding.
A larger, persistent titer carries more weight, especially in the IgG class. It still needs a second positive before it changes a diagnosis.
The labels above describe titer height in words on purpose. The cutoffs that separate low from medium-to-high vary between laboratories, and your report will print the reference range it used. What carries across every lab is the shape of the interpretation: how high, which antibody class, and above all whether it lasts.
What a positive anticardiolipin result means
People arrive at this result scared after one positive, and the honest answer is that one positive is a question, not a verdict. The antibody can rise transiently and then settle back to normal without anything else ever happening. This is why the diagnostic rules are built around time rather than a single number.
The American College of Rheumatology describes the standard plainly: a positive antiphospholipid antibody has to be confirmed twice, at least 12 weeks apart, before it counts toward a diagnosis. A passing reaction will usually be gone by the second draw. A true, persistent antibody will still be there. The 12-week wait is not bureaucratic caution; it is the actual test for whether the stamp washes off.
The other half of the story is the antiphospholipid carrier. MedlinePlus and the ACR both note that some people carry these autoantibodies for years and never have a clot or a recurrent pregnancy loss. They are positive, repeatedly, and well. Carrying the antibody is not the same as having the disease, which is why a result on its own is never enough to act on.
When a persistent antibody does line up with a clotting event, the condition is antiphospholipid syndrome (APS). MedlinePlus estimates it affects roughly 1 in 2,000 people. It mostly affects women, often between the ages of 30 and 40, and it travels with other autoimmune disease: the ACR reports that about 40 percent of people with lupus also test positive for antiphospholipid antibodies, while MedlinePlus puts the share of lupus patients who meet full APS criteria at 10 to 15 percent. If you are working through lupus markers such as ANA or anti-dsDNA, a positive aCL is read in that fuller context.
What can push anticardiolipin antibodies up
-
A recent viral or bacterial infection
MedlinePlus describes the antibodies being produced when the body meets germs whose proteins resemble its own. These post-infection rises are the classic transient positive.
-
Lupus and related autoimmune disease
Antiphospholipid antibodies cluster with systemic lupus and other connective-tissue conditions, where a positive carries more weight.
-
Genuine antiphospholipid syndrome
A persistent, often medium-to-high antibody that does not fade on the repeat draw, especially when paired with a clot or pregnancy loss.
What a negative or fading result means
A negative anticardiolipin result means no meaningful antibody was found, and a previously positive result that turns negative on the repeat draw is exactly the outcome the 12-week protocol is built to catch. That second, in-range reading is what lets a clinician set the first one aside as a transient reaction. It is the morning the stamp has finally washed off.
This is also where the IgG-versus-IgM detail comes in. A reader whose IgM was positive but IgG was normal is often looking at one of the most likely results to fade. A low positive or an isolated IgM tends to be read with more caution than a high, persistent IgG, though that judgment belongs to the doctor holding the full panel.
What to do with a positive result
-
1
Start with the doctor who ordered it
Bring the actual report. The antibody class (IgG or IgM) and the titer height change how the result is read, and those details are on the page.
-
2
Mention any recent illness
A cold, flu, or other infection in the weeks before the draw is directly relevant, because it is a common reason for a transient positive.
-
3
Expect a repeat draw, not an immediate label
Per ACR guidance, the test is repeated at least 12 weeks later. Confirmation over time is what separates a blip from a diagnosis.
-
4
Ask what else was tested
Anticardiolipin is rarely read alone. Clinicians usually look at it beside the lupus anticoagulant and clotting times such as the aPTT before drawing conclusions.
Reading anticardiolipin in context
No single anticardiolipin value tells you much. Its meaning lives in two dimensions the snapshot cannot show: whether it persists across the 12-week gap, and what the rest of the antiphospholipid workup looks like beside it. That is why this marker rewards a trend far more than a one-off reading, and why a result that fades on retest is genuinely good news rather than a contradiction.
If you are working through a positive, the guide to reading an autoimmune panel lays out how aCL sits alongside the other antibodies, and the repeat draw is where the real answer comes from. The first positive opens the question. The second one, weeks later, is what answers it.
See your Anticardiolipin Antibodies on one timeline.
BloodSight calibrates the reference range to your sex, age, and lab — and shows every value across every visit.
In your personal range
Normal ranges
| Group | Range | Unit |
|---|---|---|
| Adult Male | 0–20 | GPL/MPL units |
| Adult Female | 0–20 | GPL/MPL units |
Reference ranges may vary by laboratory and individual factors.
Anticardiolipin Antibodies — Common Questions
If my anticardiolipin test is positive, do I have antiphospholipid syndrome?
Why does the antibody need to be retested 12 weeks later?
Can a recent cold, flu, or infection make this test positive?
What does it mean to be an antiphospholipid carrier with no symptoms?
Does an IgM-only or low positive matter as much as a high IgG result?
I have lupus — does a positive anticardiolipin result change anything?
Disclaimer
This content is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Reference ranges may vary by laboratory. Always discuss your results with a qualified healthcare professional.
Related Tests
Three antibodies tested together, reported as positive or negative. The surprise is how little a lone positive usually means and how much the full set does.
The most misleading name in the coagulation panel: it points to bleeding and to lupus, and usually means neither.
A positive ANA is the most over-read result in routine bloodwork. The word 'positive' is only the start of the sentence: the titer and the pattern are what carry the meaning.
A near-perfect lupus marker with a catch: three lab methods measure it three different ways, and their numbers don't translate.
aPTT times one arm of the clotting cascade, the one heparin acts on. Its great paradox: a prolonged result can point to a clotting risk, not a bleeding one.